1/3
Export Ready

GEMDRONIC 5MG

Sold by melizza lifescience · Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Price
Price on request
In stock
Inclusive of all taxes
Minimum order: 1 Centimetre

Export Snapshot

MOQ
1 Centimetre
Lead time
On request
Packaging
Single-dose vial of 100 mL
Shelf life / longevity
As per product specification
HS Code
On request
Origin
India
Port of dispatch
On request
Export markets served
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
Values shown are for melizza lifescience.
Compliance & Certifications
Suitable for

Importers · Distributors · Wholesalers

Know your supplier

melizza lifescience is a Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup based in Rajkot Gujarat India.

Rajkot Dispatch on request Verified seller
melizza lifescience logo

melizza lifescience

Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

Established
Not shared
Employees
–
GST
24GQFPM5460R1Z4
IEC code
GQFPM5460R
Export markets
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
GlobalLinker Member Since
Aug 2025
Turnover
Incorporation Type
On request
Verified Seller
Product details

What are the specifications of this product?

Overview

Product Name: Gemdronic 5mg Injection Generic Name: Zoledronic Acid 5 mg/100 mL Manufacturer: (Marketed under various oncology/critical care brands; “Gemdronic” is one such brand) Therapeutic Category: Oncology / Bone Health (Bisphosphonate) Product Description: Gemdronic Injection contains Zoledronic Acid, a potent bisphosphonate that inhibits bone resorption. It is commonly used to treat hypercalcemia of malignancy, bone metastases, multiple myeloma, and osteoporosis. By blocking osteoclast-mediated bone breakdown, Zoledronic Acid strengthens bone, reduces skeletal complications, and helps lower elevated blood calcium levels caused by cancers. Indications: • Hypercalcemia of malignancy (tumor-induced high calcium levels) • Bone metastases from solid tumors • Multiple myeloma (skeletal-related events prevention) • Osteoporosis (postmenopausal, glucocorticoid-induced, male osteoporosis) • Paget’s disease of bone Mechanism of Action: • Zoledronic Acid binds to bone mineral and inhibits osteoclast activity, reducing bone resorption. • Decreases release of calcium from bone, preventing skeletal complications.

Product Description

Dosage & Administration:

• Administered as intravenous infusion only.

• 5 mg once yearly (for osteoporosis).

• 4 mg every 3–4 weeks (for oncology indications such as bone metastases).

• Dose and frequency depend on indication and patient’s renal function.

(Must be given by a healthcare professional under strict supervision.)


Key Benefits:

• Reduces risk of fractures and bone complications in cancer patients.

• Long-lasting bone protection with infrequent dosing.

• Effective in lowering high calcium levels caused by tumors.


Packaging:

• Single-dose vial: 100 mL solution containing 5 mg Zoledronic Acid.


Storage:

• Store below 30°C.

• Do not freeze.

• Protect from light.


Important Notes:

• For hospital/oncology use only.

• Not recommended in patients with severe kidney impairment.

• Adequate hydration before and after infusion is essential.

• Calcium and vitamin D supplementation may be required during treatment.


ONCOLOGY SUPPLIER

Melizza Lifescience

Description provided by melizza lifescience.

Specifications

Generic Name Zoledronic Acid
Brand Name Gemdronic
Concentration 5 mg/100 mL
Therapeutic Category Oncology / Bone Health (Bisphosphonate)
Indications Hypercalcemia of malignancy, Bone metastases, Multiple myeloma, Osteoporosis, Paget's disease of bone
Dosage Forms Injectable solution
Route of Administration Intravenous infusion
Manufacturer Multiple brands including Gemdronic
Storage Conditions Store below 30°C, avoid freezing, protect from light
Packaging Single-dose vial of 100 mL

Use cases

Category Pharmaceuticals > Oncology Medicines > Bone Modifying Agents
Primary application Wholesale, distribution, and international sourcing
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging Single-dose vial of 100 mL
Storage condition As recommended by supplier
Origin India
Form As listed by supplier

Commercials (this seller)

Minimum order 1 Centimetre
Lead time On request
Payment terms As per negotiated commercial agreement.
Checkout type enquiry
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing GEMDRONIC 5MG. Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the recommended dosing schedule for Gemdronic 5mg Injection in oncology indications?
A: For oncology indications such as bone metastases, the recommended dosage of Gemdronic is 4 mg administered via intravenous infusion every 3 to 4 weeks. The dosage frequency can vary depending on the patient's renal function and specific cancer treatment plan.
Q: Can Gemdronic 5mg be used for treating osteoporosis?
A: Yes, Gemdronic 5mg Injection is approved for osteoporosis treatment with a recommended dose of 5 mg administered once yearly as an intravenous infusion.
Q: What are the storage instructions for Gemdronic Injection?
A: Gemdronic Injection must be stored below 30°C, should not be frozen, and must be protected from light to maintain stability and effectiveness.
Q: Is Gemdronic safe to use in patients with renal impairment?
A: Gemdronic is not recommended for use in patients with severe kidney impairment due to risk of nephrotoxicity. Renal function should be assessed before administration, and adequate hydration is essential.
Q: What precautions should be taken during administration of Gemdronic 5mg Injection?
A: Gemdronic should be administered intravenously under strict medical supervision with patient hydration before and after infusion to reduce kidney toxicity. Calcium and vitamin D supplementation may also be necessary during treatment.
Question not answered? Ask sellers directly — typical response within 4 hours.

What similar products are available in this category?

Browse all in category
View all →
remtrex 2.5mg, 15mg,
remtrex 2.5mg, 15mg,
Price on request MOQ 1 Centimetre
View Product
altanib nova imatinib 400mg tablets
altanib nova imatinib 400mg tablets
Price on request MOQ 1 Centimetre
View Product
erlocip 150mg
erlocip 150mg
Price on request MOQ 1 Centimetre
View Product
gemdronic 5mg
gemdronic 5mg
Price on request MOQ 1 Centimetre
View Product
lucrin depot 3.75 mg / 11.25 mg injection
lucrin depot 3.75 mg / 11.25 mg injection
Price on request MOQ 1 Centimetre
View Product
truvada-tablets
truvada-tablets
Price on request MOQ 1 Centimetre
View Product
abstet 250mg tablet (abiraterone acetate (250mg))
abstet 250mg tablet (abiraterone acetate (250mg))
Price on request MOQ 1 Piece
View Product
capeta nova 500mg
capeta nova 500mg
Price on request MOQ 1 Centimetre
View Product
GEMDRONIC 5MG
GEMDRONIC 5MG
Price on request · MOQ 1Centimetre